Dr. med. Marcel Vetter

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

How Much Liver Tissue Is Required for Sufficient Histological Staging in Patients with Primary Biliary Cholangitis? (2020) Vetter M, Kremer A, Agaimy A, Pfeifer L, Neurath M, Zopf S, Siebler J Journal article Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases (2020) Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer A, Vetter M, et al. Journal article International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Functional connectivity reveals altered activation of distinct brain areas in pruritus of cholestasis (2018) Kremer A, Buchwald T, Vetter M, Dörfler A, Forster C Conference contribution Primary biliary cholangitis-established and novel therapies (2018) Vetter M, Kremer A Journal article Treatment Perspectives in Crohn's Disease (2018) Vetter M, Neurath M Journal article Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients (2018) Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, et al. Conference contribution Crohn's disease - use of biomarkers in general practice (2017) Vetter M, Neurath MF, Atreya R Journal article Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity (2017) Knieling F, Neufert C, Hartmann A, Claussen J, Urich A, Egger C, Vetter M, et al. Journal article, Letter Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges (2017) Vetter M, Neurath M Journal article